Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)

By Holme Ingar   Cater Nilo   Faergeman Ole   Kastelein John   Olsson Anders   Tikkanen Matti   Lytken Larsen Mogens   Lindahl Christina   Pedersen Terje  

Annals of Medicine, Vol. 40, Iss. 6, 2008-01 ,pp. : 456-464

Informa Healthcare

Access to resources Recommend Favorite

Association of Apolipoprotein J Polymorphism 1598delT with Coronary Artery Disease and Lipoprotein Levels

By  

Cardiology, Vol. 118, Iss. 2, 2011-04 ,pp. : 83-92

Karger

Access to resources Recommend Favorite

Plasma C-Reactive Protein and Lipoprotein Levels, and Progression of Coronary Artery Disease after Myocardial Infarction Treated with Thrombolysis

By  

Cardiology, Vol. 104, Iss. 2, 2005-08 ,pp. : 65-71

Karger

Access to resources Recommend Favorite

ATP-Binding Cassette Transporter A1 Gene I823M Polymorphism Affects Plasma High-Density Lipoprotein Cholesterol Level and Modifies the Effect of Low High-Density Lipoprotein Cholesterol on the Risk of Coronary Artery Disease

By  

Cardiology, Vol. 107, Iss. 4, 2007-01 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

Oxidized Low-Density Lipoprotein Cholesterol and Coronary Artery Disease

By  

Cardiology, Vol. 119, Iss. 2, 2011-09 ,pp. : 106-107

Karger

Access to resources Recommend Favorite